全结肠切除回肠直肠吻合术与次全结肠切除盲肠直肠吻合术治疗慢传输型便秘:多中心随机对照试验(STOPS试验)方案
STOPS试验为前瞻性、随机、多中心对照临床试验,计划纳入252例成人慢传输型便秘患者,按1:1随机分为全结肠切除回肠直肠吻合术(TC-IRA)组与次全结肠切除盲肠直肠吻合术(SC-CRA)组,主要结局为Wexner便秘评分,术后随访至36个月,旨在比较两种术式的疗效与安全性。
要点
- 慢传输型便秘保守治疗无效者可考虑手术,传统术式为TC-IRA,SC-CRA因可能减少术后腹泻而受关注。
- STOPS试验计划纳入252例成人患者,1:1随机分配至TC-IRA组或SC-CRA组。
- 主要结局为Wexner便秘评分,术后1、3、6、12、24、36个月评估。
核心结论
- 该试验将是首个且规模最大的随机临床试验,评估TC-IRA与SC-CRA在Wexner便秘评分结局上孰应成为慢传输型便秘的标准化手术治疗。
- 研究者希望其发现不仅能证明该手术在慢传输型便秘治疗中的价值,还能为慢传输型便秘手术治疗的进一步标准化提供更可靠的临床证据。
研究设计与样本
- STOPS试验为前瞻性、随机、多中心对照临床试验,比较TC-IRA与SC-CRA治疗慢传输型便秘患者的效果。
- 筛选合格并签署知情同意后,共252例成人患者将在确认无排除标准后按1:1比例随机分为两组。
- 主要结局为Wexner便秘评分,次要结局包括手术时间、中转开腹率、失血量、短期和长期并发症、排便次数、腹痛、腹胀、排便费力、灌肠使用、泻药使用、Wexner失禁评分、胃肠道生活质量指数(GIQLI)、36项简短健康调查(SF-36)及满意度。
- 结局在基线及术后1、3、6、12、24、36个月评估。
- 试验注册号NCT05352074,注册日期2022年4月3日。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Constipation, a prevalent gastrointestinal disorder, affects 10%-15% of adults in the USA and approximately 8.2% of China's general population. Slow transit constipation (STC), accounting for 15%-42% of constipation cases, is defined by impaired colonic motility. For patients refractory to conservative treatment who experience chronic, intractable symptoms and diminished quality of life, surgical intervention becomes the treatment of last resort. The primary surgical approach for STC has traditionally been total colectomy with ileorectal anastomosis (TC-IRA). However, over the past two decades, subtotal colectomy with cecorectal anastomosis (SC-CRA) has gained increasing attention among clinicians due to its potential to reduce postoperative diarrhea. Despite this advantage, SC-CRA is also associated with concerns regarding an increased risk of recurrent constipation. The debate surrounding which approach is superior persists. This study aims to resolve this controversy through a comparative analysis of TC-IRA and SC-CRA, evaluating their therapeutic efficacy and safety profiles in refractory STC. METHODS: The STOPS trial is a prospective, randomized, multicenter-controlled clinical trial to compare the effectiveness of TC-IRA versus SC-CRA in treating patients with STC. After screening for eligibility and obtaining informed consent, a total of 252 adult patients will be randomized into two groups in a 1:1 ratio after assuring that none of the exclusion criteria is present. The primary outcome is the Wexner Constipation Score. The secondary outcomes include operative time, conversion rates, blood loss, short- and long-term complications, bowel movements, abdominal pain, bloating, straining, enema use, laxative use, Wexner Incontinence Score, gastrointestinal quality of life index (GIQLI), 36-item Short Form Health Survey (SF-36), and satisfaction. Outcomes will be assessed at baseline and at 1, 3, 6, 12, 24, and 36 months postoperatively. DISCUSSION: This trial will be the first and largest randomized clinical trial to assess whether TC-IRA or SC-CRA should be the standardized surgical treatment for STC in terms of WCS outcomes. We hope that its findings will not only demonstrate the value of the surgical procedure in the treatment of STC, but also provide more reliable clinical evidence for further standardization of STC surgical treatment. TRIAL REGISTRATION: STOPS Trial: A Multicentre Prospective Randomised Clinical Trial Comparing Total Colectomy with Ileorectal Anastomosis Versus Subtotal Colectomy with Cecal-rectal Anastomosis for Slow Transit Constipation ( http://clinicaltrials.gov/ct2/show/NCT05352074 ). Registry identifier: NCT05352074. Registration date: April 3, 2022.
引用
- Tian Y, Guo M, Bu F, et al. Total colectomy with ileorectal anastomosis versus subtotal colectomy with cecal-rectal anastomosis for slow transit constipation: protocol for a multicenter randomized controlled trial (STOPS trial). Trials. 2025. PMID: 41074220. doi:10.1186/s13063-025-09049-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。